{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T03:26:20Z","timestamp":1787109980384,"version":"build-2736575974"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018916","name":"Suzhou Municipal Health Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018916","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ejps.2026.107626","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T06:48:41Z","timestamp":1785394121000},"page":"107626","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Investigating gut microbiota and their metabolites as biomarkers for tacrolimus pharmacokinetic variability"],"prefix":"10.1016","volume":"225","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-1762-7969","authenticated-orcid":false,"given":"Yan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linkun","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoliang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linsheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8481-0630","authenticated-orcid":false,"given":"Liyan","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2026.107626_bib0001","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2025.1559033","article-title":"Significant changes in gut microbiota and SCFAs among patients with newly diagnosed acute myeloid leukemia","volume":"16","author":"An","year":"2025","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejps.2026.107626_bib0002","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfae214","article-title":"Kidney transplantation and gut microbiota","volume":"17","author":"Chen","year":"2024","journal-title":"Clin. Kidney J."},{"key":"10.1016\/j.ejps.2026.107626_bib0003","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1023\/A:1010914624111","article-title":"Characterizing the expression of CYP3A4 and efflux transporters (P-gp, MRP1, and MRP2) in CYP3A4-transfected caco-2 cells after induction with sodium butyrate and the phorbol ester 12-O-tetradecanoylphorbol-13-acetate","volume":"18","author":"Cummins","year":"2001","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2026.107626_bib0004","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/cpt.3077","article-title":"Tacrolimus pharmacokinetics is associated with gut microbiota diversity in kidney transplant patients: results from a pilot cross-sectional study","volume":"115","author":"Degraeve","year":"2024","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2026.107626_bib0005","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s40168-023-01578-y","article-title":"Gut microbiome modulates tacrolimus pharmacokinetics through the transcriptional regulation of ABCB1","volume":"11","author":"Degraeve","year":"2023","journal-title":"Microbiome"},{"key":"10.1016\/j.ejps.2026.107626_bib0006","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/ajt.12588","article-title":"Human microbiota characterization in the course of renal transplantation","volume":"14","author":"Fricke","year":"2014","journal-title":"Am. J. Transpl."},{"key":"10.1016\/j.ejps.2026.107626_bib0007","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/ijc.2910550221","article-title":"Variable effects of sodium butyrate on the expression and function of the MDR1 (P-glycoprotein) gene in colon carcinoma cell lines","volume":"55","author":"Frommel","year":"1993","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ejps.2026.107626_bib0008","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.mib.2017.11.030","article-title":"Evolution of virulence in Enterococcus faecium, a hospital-adapted opportunistic pathogen","volume":"41","author":"Gao","year":"2018","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.ejps.2026.107626_bib0009","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1111\/ajt.16002","article-title":"A comprehensive review of the impact of tacrolimus intrapatient variability on clinical outcomes in kidney transplantation","volume":"20","author":"Gonzales","year":"2020","journal-title":"Am. J. Transpl."},{"key":"10.1016\/j.ejps.2026.107626_bib0010","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1124\/dmd.118.084772","article-title":"Commensal gut bacteria convert the immunosuppressant tacrolimus to less potent metabolites","volume":"47","author":"Guo","year":"2019","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2026.107626_bib0011","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.ajt.2025.02.010","article-title":"Gut microbiome alterations precede graft rejection in kidney transplantation patients","volume":"25","author":"Holle","year":"2025","journal-title":"Am. J. Transpl."},{"key":"10.1016\/j.ejps.2026.107626_bib0012","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.anclin.2017.04.001","article-title":"Overview of immunosuppressive therapy in solid organ transplantation","volume":"35","author":"Holt","year":"2017","journal-title":"Anesth. Clin."},{"key":"10.1016\/j.ejps.2026.107626_bib0013","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/j.cell.2020.05.001","article-title":"Personalized mapping of drug metabolism by the Human gut microbiome","volume":"181","author":"Javdan","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ejps.2026.107626_bib0014","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0233646","article-title":"Gut microbial diversity, inflammation, and oxidative stress are associated with tacrolimus dosing requirements early after heart transplantation","volume":"15","author":"Jennings","year":"2020","journal-title":"PLoS. One"},{"key":"10.1016\/j.ejps.2026.107626_bib0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0227373","article-title":"Gut microbiota composition alterations are associated with the onset of diabetes in kidney transplant recipients","volume":"15","author":"Lecronier","year":"2020","journal-title":"PLoS. One"},{"key":"10.1016\/j.ejps.2026.107626_bib0016","article-title":"Gut microbiota and tacrolimus dosing in kidney transplantation","volume":"10","author":"Lee","year":"2015","journal-title":"PLoS. One"},{"key":"10.1016\/j.ejps.2026.107626_bib0017","first-page":"697","article-title":"Gut microbial community structure and complications after kidney transplantation: a pilot study","volume":"98","author":"Lee","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.ejps.2026.107626_bib0018","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1111\/j.1600-6143.2005.00844.x","article-title":"Cytochrome P450 3A4 and P-glycoprotein activity and assimilation of tacrolimus in transplant patients with persistent diarrhea","volume":"5","author":"Lemahieu","year":"2005","journal-title":"Am. J. Transpl."},{"key":"10.1016\/j.ejps.2026.107626_bib0019","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/j.ajt.2024.01.012","article-title":"OPTN\/SRTR 2022 annual data report: kidney","volume":"24","author":"Lentine","year":"2024","journal-title":"Am. J. Transpl."},{"key":"10.1016\/j.ejps.2026.107626_bib0020","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1186\/s12967-022-03825-6","article-title":"Integrative metagenomic and metabolomic analyses reveal the role of gut microbiota in antibody-mediated renal allograft rejection","volume":"20","author":"Li","year":"2022","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ejps.2026.107626_bib0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19490976.2021.1875796","article-title":"Blautia-a new functional genus with potential probiotic properties?","volume":"13","author":"Liu","year":"2021","journal-title":"Gut. Microb."},{"key":"10.1016\/j.ejps.2026.107626_bib0022","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2022.2143220","article-title":"Kidney microbiota dysbiosis contributes to the development of hypertension","volume":"14","author":"Liu","year":"2022","journal-title":"Gut. Microb."},{"key":"10.1016\/j.ejps.2026.107626_bib0023","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/1462-2920.13589","article-title":"Formation of propionate and butyrate by the human colonic microbiota","volume":"19","author":"Louis","year":"2017","journal-title":"Env. Microbiol."},{"key":"10.1016\/j.ejps.2026.107626_bib0024","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1034\/j.1600-6143.2002.21018.x","article-title":"Differential effect of diarrhea on FK506 versus cyclosporine A trough levels and resultant prevention of allograft rejection in renal transplant recipients","volume":"2","author":"Maes","year":"2002","journal-title":"Am. J. Transpl."},{"key":"10.1016\/j.ejps.2026.107626_bib0025","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau6323","article-title":"Discovery and inhibition of an interspecies gut bacterial pathway for Levodopa metabolism","volume":"364","author":"Maini Rekdal","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.ejps.2026.107626_bib0026","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/jpn.12416","article-title":"Feed-drug interaction of orally applied butyrate and phenobarbital on hepatic cytochrome P450 activity in chickens","volume":"100","author":"Matis","year":"2016","journal-title":"J. Anim. Physiol. Anim. Nutr. (Berl)"},{"key":"10.1016\/j.ejps.2026.107626_bib0027","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1126\/science.1223813","article-title":"Host-gut microbiota metabolic interactions","volume":"336","author":"Nicholson","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.ejps.2026.107626_bib0028","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.3390\/ijms24021260","article-title":"The effect of the gut microbiota on transplanted kidney function","volume":"24","author":"Przybycinski","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejps.2026.107626_bib0029","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262411897","article-title":"Gut microbiota in the regulation of intestinal drug transporters: molecular mechanisms and pharmacokinetic implications","volume":"26","author":"Rzeczycki","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejps.2026.107626_bib0030","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/s41586-022-05438-x","article-title":"Enterococci enhance clostridioides difficile pathogenesis","volume":"611","author":"Smith","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ejps.2026.107626_bib0031","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrmicro.2016.17","article-title":"The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism","volume":"14","author":"Spanogiannopoulos","year":"2016","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejps.2026.107626_bib0032","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2165\/00003088-200645020-00003","article-title":"Pharmacokinetic interaction between Levofloxacin and Ciclosporin or Tacrolimus in Kidney transplant recipients","volume":"45","author":"Stefano","year":"2006","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2026.107626_bib0033","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/s41467-019-08294-y","article-title":"Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson's disease","volume":"10","author":"Van Kessel","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejps.2026.107626_bib0034","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3109\/03602532.2016.1151037","article-title":"Clinical determinants of calcineurin inhibitor disposition: a mechanistic review","volume":"48","author":"Vanhove","year":"2016","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.ejps.2026.107626_bib0035","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adg8357","article-title":"Integrating the gut microbiome and pharmacology","volume":"16","author":"Verdegaal","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejps.2026.107626_bib0036","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1111\/jphp.13276","article-title":"Gut microbiome-mediated modulation of hepatic cytochrome P450 and P-glycoprotein: impact of butyrate and fructo-oligosaccharide-inulin","volume":"72","author":"Walsh","year":"2020","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejps.2026.107626_bib0037","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1136\/gutjnl-2019-320204","article-title":"Interaction between drugs and the gut microbiome","volume":"69","author":"Weersma","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.ejps.2026.107626_bib0038","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/s41579-024-01058-6","article-title":"Enterococcus faecium: evolution, adaptation, pathogenesis and emerging therapeutics","volume":"22","author":"Wei","year":"2024","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejps.2026.107626_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.trre.2021.100668","article-title":"Impact of gut microbiota on kidney transplantation","volume":"36","author":"Winichakoon","year":"2022","journal-title":"Transpl. Rev."},{"key":"10.1016\/j.ejps.2026.107626_bib0040","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/s41401-020-0402-x","article-title":"Short-chain fatty acids exert opposite effects on the expression and function of p-glycoprotein and breast cancer resistance protein in rat intestine","volume":"42","author":"Xie","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejps.2026.107626_bib0041","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1124\/dmd.122.001173","article-title":"Antibiotics-induced depletion of rat microbiota induces changes in the expression of host drug-processing genes and pharmacokinetic behaviors of CYPs probe drugs","volume":"51","author":"Yang","year":"2023","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2026.107626_bib0042","article-title":"Identification of antibiotic administration as a potentially novel factor associated with Tacrolimus trough variability in kidney transplant recipients: a preliminary study","volume":"5","author":"YuanPu","year":"2019","journal-title":"Transpl. Direct"},{"key":"10.1016\/j.ejps.2026.107626_bib0043","article-title":"Distribution characteristics and impacting factors of drug CYP enzymes and transporters in the gastrointestinal tract of Chinese healthy subjects","author":"Zhang","year":"2024","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2026.107626_bib0044","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s00228-025-03825-7","article-title":"Exploring the comprehensive factors influencing tacrolimus pharmacokinetics in early renal transplant recipients: a population pharmacokinetic analysis","volume":"81","author":"Zhang","year":"2025","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2026.107626_bib0045","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/CAD.0000000000000588","article-title":"Sodium butyrate increases P-gp expression in lung cancer by upregulation of STAT3 and mRNA stabilization of ABCB1","volume":"29","author":"Zhao","year":"2018","journal-title":"Anticancer Drug."},{"key":"10.1016\/j.ejps.2026.107626_bib0046","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/s41586-019-1291-3","article-title":"Mapping human microbiome drug metabolism by gut bacteria and their genes","volume":"570","author":"Zimmermann","year":"2019","journal-title":"Nature"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098726002009?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098726002009?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T02:42:17Z","timestamp":1787107337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098726002009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":46,"alternative-id":["S0928098726002009"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107626","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigating gut microbiota and their metabolites as biomarkers for tacrolimus pharmacokinetic variability","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107626","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107626"}}